Funding for this research was provided by:
Takeda Pharmaceutical Company
Article History
First Online: 25 October 2019
Compliance with Ethical Standards
:
: This review was funded by Takeda Pharmaceutical Co. Ltd.
: Kohei Kaku has received grants/pending grants from Boehringer Ingelheim Japan, Mitsubishi Tanabe-Pharma, and Taisho Toyama Pharmaceutical; consulting fees/honorarium from Sanwa Kagaku Kenkyusho; payment for lectures including services on speakers bureaus from Astellas Pharma, AstraZeneca, Boehringer Ingelheim Japan, Elli Lilly Japan, MSD, Novo Nordisk Pharma, Ono-Yakuhin, Sanwa Kagaku Kenkyusho, Taisho Toyama Pharmaceutical, and Takeda Pharmaceutical Company Limited. Koichi Kisanuki, Mari Shibata, and Takashi Oohira are employees of Takeda Pharmaceutical Company Limited.